IGA Chair of Ophthalmology for Glaucoma and Allied Studies

Professor David (Ted) Garway-Heath

Moorfields Eye Hospital and UCL Institute of Ophthalmology, London, UK

David Garway-Heath is International Glaucoma Association (IGA) Professor of Ophthalmology for Glaucoma & Allied Studies at University College London (UCL), Honorary Consultant Ophthalmologist at Moorfields Eye Hospital, and Head of Vision Assessment & Imaging Research at the NIHR (National Institute for Health Research) Biomedical Research Centre based at Moorfields Eye Hospital and UCL Institute of Ophthalmology.

In addition to his clinical work, Professor Garway-Heath’s research focuses on the development and evaluation of techniques for effective diagnosis, monitoring and management of glaucoma, the identification of risk factors for glaucoma progression, and decision-support systems for healthcare delivery services. He has managed to attract funding for his research totalling over £4 million over the last 5 years, and is the author of nearly 200 peer-reviewed publications. Professor Garway-Heath was bestowed the prestigious Alcon Research Institute Award for ‘outstanding contributors to ophthalmic research’ as well as the World Glaucoma Association Research Recognition Award. He has been reappointed Senior Investigator of the National Institute for Health Research (NIHR), one of only few positions in ophthalmology in the UK, and was also cited, for the second time, as one of the 100 most influential people in ophthalmology worldwide in The Ophthalmologist magazine power list.

His contributions to the understanding of the relationship between structural and functional changes in Glaucoma are reflected in the anatomical map that he developed (also known as the Garway-Heath map), which is used worldwide in research in this field. His pioneering work in imaging has contributed to an ever-increasing use of the technique in glaucoma management. The Moorfields Regression Analysis algorithm, which he developed for one of the earliest diagnostic devices, was selected by University College London to showcase the university’s excellence in research in clinical medicine. Another example of his success in translational research can be seen in the publication The Lancet of his landmark trial, the UK Glaucoma Treatment Study. This is the first time that an important trial in Glaucoma was published in this high-impact journal. The findings of significant clinical importance showed that it was possible to reduce considerably the period needed to identify treatment effects, thus increasing the likelihood of bringing new drugs more quickly and more cost-effectively to patients.

Membership of professional/national/regional bodies:

  • President of the European Glaucoma Society
  • Vice President of the International Imaging and Perimetry Society
  • Chair of the Membership Committee of the International Glaucoma Research Society
  • Co-Chair, Consensus Committee, World Glaucoma Association (2016, 2011, 2007)
  • Secretary to the Imaging Morphometry Association for Glaucoma in Europe
  • Fellow of the Association for Research in Vision and Ophthalmology (Chair, Glaucoma Program Committee 2008-9)
  • Fellow of the Royal College of Ophthalmologists
  • Member of the American Ophthalmological Society
  • Member of the UK and Eire Glaucoma Society (Chair 2010)
  • Member of the American Academy of Ophthalmology (Achievement Award 2006)

Professor Garway-Heath also chairs the Design Steering Group for the combined new building for Moorfields Eye Hospital and Institute of Ophthalmology, and sits on the Research Strategy Board of Moorfields Eye Hospital and the Institute of Ophthalmology.